Only a week after ARCH Venture Partners and Flagship Pioneering raised huge venture capital funds aimed at life sciences, Deerfield Management announced the closing of the Deerfield Healthcare Innovations Fund II with $840 million. The fund will focus on investing in science startups related to new therapies and technology related to “improve the way healthcare is delivered to patients.”
